According to the present data, TCA directly enhances invasiveness of ESCC-DR cells in vitro, which is associated with TGF-β1 release from cancer cells; TCA also indirectly accelerates tumor growth (by reducing cell loss) in vivo through the promotion of angiogenesis mediated by the migration of vascular endothelial cells. Here, TGFB1 is linked to neoplasm.